IP Verse

Altergon competitive analysis

Latest publications and patents of Altergon New

Explore the latest publications and patents granted to Altergon, showcasing their recent innovations and technological advancements.

Last updated on: Sep 25, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Altergon

EP3056187
Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4Patent Maintained As Amended
EP2034956
Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic CystitisPatent Maintained As Amended
EP3528847
Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid HormoneGranted And Under Opposition
EP2925369
Jan 3, 2018Aqueous Oral Solutions Of Steroid Hormones And Hydroxypropyl-Beta-Cyclodextrin With Optimised BioavailabilityNo Opposition Filed Within Time Limit

Latest patents of Altergon opposed by its competitors

Explore Altergon's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3056187
Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T41
EP2034956
Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic Cystitis1
EP3528847
Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid Hormone1

Latest PTAB cases involving Altergon

Discover the latest PTAB cases involving Altergon, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Altergon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ALTERGON - 3 - - Non-Active
STREHLKE3 - - - Highly Aggressive
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES2 - - - Highly Aggressive